|

TYK-00540 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • TYK Medicines, Inc2

Indications

  • Cancer2
  • Locally Advanced or Metastatic Solid Tumors1
  • HR-positive, HER2-negative Advanced Breast Cancer1
  • Breast Cancer1

Other2 trials

A Study of TYK-00540 in Adult Patients With Solid Tumors
Phase 1
Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.